RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
ClinicalTrials.gov NCT05202808
Research payments
$1,842,433
Through program year 2022, $1,842,433 in research payments was reported against RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study, across 515 payments, paid by RxSight Inc.
- Paid by
- RxSight Inc
- ClinicalTrials.gov
- NCT05202808
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $1,804,388 | 484 |
| 2021 | Research | $38,044 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- William Wiley Cleveland, OH Named on 15 payments
- Jeffrey Whitman Dallas, TX Named on 13 payments
- Vance Thompson Sioux Falls, SD Named on 9 payments
- Kenneth Maverick San Antonio, TX Named on 9 payments
- Stephen Slade Houston, TX Named on 9 payments
- Steven VOLD Fayetteville, AR Named on 8 payments
- Deborah Ristvedt Alexandria, MN Named on 8 payments
- Gang Hu Hurst, TX Named on 7 payments
- Brandon Baartman Sioux Falls, SD Named on 7 payments
- Eva Liang Las Vegas, NV Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.